Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (801-810 of 811) with videos related to

Pageof 82
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Dyslipidaemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumoursJames Hugo Armstrong Clubb, Santeri Artturi Pakola, Sakari Joenväärä, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert surveyGlenn Geidel, Nathan Fekade, Katharina Raabe, et al.
Cancer|May 12, 2020
Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 womenStephen W Duffy, László Tabár, Amy Ming-Fang Yen, et al.
Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2026
Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLCRikke Andersen, Mette Syberg Jespersen, Mario Presti, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 11, 2024
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS studyGiulio Conte, Marco Bergonti, Vincent Probst, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2025
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence studyMichael Weichenthal, Eva Ellebaek, Joanna Mangana, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2021
Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorderJérémie Courraud, Eric Chater-Diehl, Benjamin Durand, et al.
The New England Journal of Medicine|December 8, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced MelanomaMaartje W Rohaan, Troels H Borch, Joost H van den Berg, et al.
Pageof 82

Showing results (801-810 of 811) with videos related to

Sort By:
Pageof 82
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Dyslipidaemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumoursJames Hugo Armstrong Clubb, Santeri Artturi Pakola, Sakari Joenväärä, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert surveyGlenn Geidel, Nathan Fekade, Katharina Raabe, et al.
Cancer|May 12, 2020
Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 womenStephen W Duffy, László Tabár, Amy Ming-Fang Yen, et al.
Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2026
Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLCRikke Andersen, Mette Syberg Jespersen, Mario Presti, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 11, 2024
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS studyGiulio Conte, Marco Bergonti, Vincent Probst, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2025
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence studyMichael Weichenthal, Eva Ellebaek, Joanna Mangana, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 4, 2021
Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorderJérémie Courraud, Eric Chater-Diehl, Benjamin Durand, et al.
The New England Journal of Medicine|December 8, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced MelanomaMaartje W Rohaan, Troels H Borch, Joost H van den Berg, et al.
Pageof 82